Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development and validation of a quality of life measurement scale specific to hereditary hemorrhagic telangiectasia: the QoL-HHT

19 Jul 2022

Abstract excerpt

BACKGROUND: Hereditary hemorrhagic telangiectasia (HHT) disease is a rare genetic disorder with symptoms and complications that can significantly affect patients' daily lives. To date, no scale has been validated to assess the specific symptoms of this disease on the quality of life (QOL) of HHT patients. This makes it difficult for clinicians to accurately measure the quality of life of patients with HHT. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Vascular Anomalies and Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35854330
DOI: 10.1186/s13023-022-02426-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development and validation of a quality of life measurement scale specific to hereditary hemorrhagic telangiectasia: the QoL-HHTPMID 35854330Read ↗

Development and validation of a quality of life measurement scale specific to Hereditary Hemorrhagic Telangiectasia: The QoL-HHTSemantic proximity Read ↗

Determinants of quality of life in Hereditary Haemorrhagic Telangiectasia: the relative roles of bleeding, anaemia and visceral involvementSemantic proximity Read ↗

European Reference Network For Rare Vascular Diseases (VASCERN) Outcome Measures For Hereditary Haemorrhagic Telangiectasia (HHT)Semantic proximity Read ↗

International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia.Semantic proximity Read ↗

Integration of clinical parameters, genotype and epistaxis severity score to guide treatment for hereditary hemorrhagic telangiectasia associated bleeding.Semantic proximity Read ↗

Impact of genotype and mutation type on health-related quality of life in patients with hereditary hemorrhagic telangiectasia.Semantic proximity Read ↗

Health Outcomes Following Covid-19 Infection and Vaccination in Hereditary Hemorrhagic TelangiectasiaSemantic proximity Read ↗

Hereditary Hemorrhagic Telangiectasia in Uruguay: Epidemiologic and clinical features of the evaluated populationSemantic proximity Read ↗

“Quality of Life in Epidermolysis Bullosa” and “Epidermolysis Bullosa Burden of Disease”: Italian translation, cultural adaptation, and pilot testing of two disease-specific questionnairesSemantic proximity Read ↗

Influence of hormonal changes in patients with hereditary hemorrhagic telangiectasiaSemantic proximity Read ↗

Psychometric study of the SF-36v2 in hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE)Semantic proximity Read ↗

Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.